Conflict of Interest and Public Policies
Keywords:
Conflict of interest. Ethic research. Human subjects rights. Biomedical research.Abstract
The present paper carries out an introduction to the concept of conflict of interest in biomedical research and its antecedents on the field of the ethics of research, intending diverse definitions of conflict of individual and institutional interest. This work makes an analysis of diverse institutions proposals that tend to build a normative to control this type of ethical problems. Also, the paper makes a critical reflection about this denomination more as a strategic concept than an ethical one that puts the ethical duties of the professionals in the same level of the individual interest. The paper analyzes the States responsibilities in the protection of human rights, particularly in the human subjects of investigation that can be harmed by interests, especially financial interests and the way that the human subjects, the institutions and the own State must be protected.
Downloads
Download data is not yet available.
References
ANGELL, M. The ethics of clinical research in the third world. N Engl J Med 1997; 337: 847-849.
___________. Investigator’s responsibilities for human subjects in developing countries. Editorial. N Engl J Med 2000; 342 (13): 967- 969.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES. Task force on financial conflicts of interest in clinical research. Protecting subjects, preserving trust,
promoting progress. Policy and guidelines for the oversight of individual financial interests in human subjects research. 2001.
ASSOCIATION OF AMERICAN UNIVERSITIES. Task force on research accountability. Report on individual and institutional financial conflict of interest.
Report and Recommendations. October, 2001.
CAÑÁS, M. Ensayos clínicos y boletines independientes. Editorial. Evidencia. Actualización en la práctica ambulatoria 2005, 7 (3): 68-67.
CONFERENCE ON ETHICAL ASPECTS OF RESEARCH IN DEVELOPING COUNTRIES, 2001. Hasting Center Report. Moral standards for research in developing
countries 2004; 34 (3) 17-27.
ELLIOTT, C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Center Report 2004, 34 (5): 18-23.
EMANUEL, E & STENINER, D. Institutional conflict of interest. N Engl J Med 1995; 332 (4): 262- 268.
INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL EDITORS. Conflict of interest. Lancet 1993; 341: 742-743.
JONSEN, A. The birth of bioethics. New York, Oxford University Press, 1998: 125- 165.
LURIE, P & WOLFE, SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337: 801-808;
MARWICK, C. US Government issues guidelines on conflicts of interest in research. BMJ 2003;326:782.
MCCRARY, SV; ANDERSON, C. et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 2000; 343 (22):
1621- 1626.
PUBLIC CITIZEN REPORT. The other drug war: big pharma’s 625 Washington lobbyists, july 23, 2001, http://www.citizen.org/congress/drugs/pharmadrugwar.html.
RELMAN, A. & ANGELL, M. How the drug industry distorts medicine and politics. America’s other drug problem. The New Republic. 2002 December 16,: 27-4.
ROTHMAN, K. & MICHELS, K. Declaration of Helsinki should be strengthened. BMJ 2000; 321: 442-44.
SMITH, R. Editorial. Making progress with competing interests. BMJ 2002; 325:1375-1376
TEALDI, JC. Etica de la investigación: el principio y el fin de la bioética. Comunicación personal del autor.
TESSA, T & TORRES, E. North-South research partnerships: the ethics of carrying out research in developing countries BMJ, 1999; 319: 438- 441.
THE HASTING CENTER: Las metas de la medicina: establecer nuevas prioridades. The Hasting Center Report. Suplemento Especial, nov.- dic., 1996.
Distribuido en la Argentina por la ASOCIACIÓN ARGENTINA DE INVESTIGACIONES ÉTICAS. Comité de Ética para las Investigaciones Clínicas.
THOMPSON, DF. Understanding financial conflict of interest. N Engl J Med 1993; 329, (8): 573- 576.
TOPOL, E J. Failing the public health. Rofecoxib, Merck and the FDA. N Engl J Med 2004; 351: 1707-9.
VIDAL, SM. Acerca de la independencia de los comités de ética de la investigación. Jurisprudencia Argentina, Número especial Bioética, Lexis Nexis 2004; 5:
51-58
___________. Artículo 30 de la Declaración de Helsinki y el Informe Nuffield, en Bioética ¿Estrategia de dominación para América Latina?. Pfeiffer, ML (org.). Ediciones Suarez, Mar del Plata, 2004: 86- 98.
___________. Investigator’s responsibilities for human subjects in developing countries. Editorial. N Engl J Med 2000; 342 (13): 967- 969.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES. Task force on financial conflicts of interest in clinical research. Protecting subjects, preserving trust,
promoting progress. Policy and guidelines for the oversight of individual financial interests in human subjects research. 2001.
ASSOCIATION OF AMERICAN UNIVERSITIES. Task force on research accountability. Report on individual and institutional financial conflict of interest.
Report and Recommendations. October, 2001.
CAÑÁS, M. Ensayos clínicos y boletines independientes. Editorial. Evidencia. Actualización en la práctica ambulatoria 2005, 7 (3): 68-67.
CONFERENCE ON ETHICAL ASPECTS OF RESEARCH IN DEVELOPING COUNTRIES, 2001. Hasting Center Report. Moral standards for research in developing
countries 2004; 34 (3) 17-27.
ELLIOTT, C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Center Report 2004, 34 (5): 18-23.
EMANUEL, E & STENINER, D. Institutional conflict of interest. N Engl J Med 1995; 332 (4): 262- 268.
INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL EDITORS. Conflict of interest. Lancet 1993; 341: 742-743.
JONSEN, A. The birth of bioethics. New York, Oxford University Press, 1998: 125- 165.
LURIE, P & WOLFE, SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337: 801-808;
MARWICK, C. US Government issues guidelines on conflicts of interest in research. BMJ 2003;326:782.
MCCRARY, SV; ANDERSON, C. et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 2000; 343 (22):
1621- 1626.
PUBLIC CITIZEN REPORT. The other drug war: big pharma’s 625 Washington lobbyists, july 23, 2001, http://www.citizen.org/congress/drugs/pharmadrugwar.html.
RELMAN, A. & ANGELL, M. How the drug industry distorts medicine and politics. America’s other drug problem. The New Republic. 2002 December 16,: 27-4.
ROTHMAN, K. & MICHELS, K. Declaration of Helsinki should be strengthened. BMJ 2000; 321: 442-44.
SMITH, R. Editorial. Making progress with competing interests. BMJ 2002; 325:1375-1376
TEALDI, JC. Etica de la investigación: el principio y el fin de la bioética. Comunicación personal del autor.
TESSA, T & TORRES, E. North-South research partnerships: the ethics of carrying out research in developing countries BMJ, 1999; 319: 438- 441.
THE HASTING CENTER: Las metas de la medicina: establecer nuevas prioridades. The Hasting Center Report. Suplemento Especial, nov.- dic., 1996.
Distribuido en la Argentina por la ASOCIACIÓN ARGENTINA DE INVESTIGACIONES ÉTICAS. Comité de Ética para las Investigaciones Clínicas.
THOMPSON, DF. Understanding financial conflict of interest. N Engl J Med 1993; 329, (8): 573- 576.
TOPOL, E J. Failing the public health. Rofecoxib, Merck and the FDA. N Engl J Med 2004; 351: 1707-9.
VIDAL, SM. Acerca de la independencia de los comités de ética de la investigación. Jurisprudencia Argentina, Número especial Bioética, Lexis Nexis 2004; 5:
51-58
___________. Artículo 30 de la Declaración de Helsinki y el Informe Nuffield, en Bioética ¿Estrategia de dominación para América Latina?. Pfeiffer, ML (org.). Ediciones Suarez, Mar del Plata, 2004: 86- 98.
Downloads
How to Cite
Vidal, S. (2005). Conflict of Interest and Public Policies. Revista Brasileira De Bioética, 1(4), 386–400. Retrieved from https://www.periodicos.unb.br/index.php/rbb/article/view/8092
Issue
Section
Artigos Originais
